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Abstract This study is an analysis of26 wom.en with burning
vulva syndrom.e. They seldom. had frankly abnor-
m.a! physical findings, and application of acetic
acid and colposcopically directed biopsy are there-
fore m.andatory. Histopathological study showed
characteristic features of hum.an papillom.avirus
(HPV) in 20 patients (77%). HPV has been shown
to be a cause of vulvar vestibulitis syndrom.e and
was an associated problem. in 3 of the 5 patients
who had essential or dysaesthetic vulvodynia. The
latter is sim.ilar to causalgia, with a poor prognosis
for resolution. Single patients had the following
specific conditions: lichen planus, lichen sclero-
sus, m.ature neurom.a and chronic candidiasis.
The study shows that vulvodynia is a m.ultifac-
toria! problem. for which m.anagem.ent strategies
have evolved over the course of tilDe. Although
interferon-a-2b offers m.uch prom.ise for the treat-
m.ent of vulvodynia caused by subclinical HPV
infection, the com.plete cure rate was only 58%.
Overall 38% of patients still experience their prob-
lem., which indicates that they should be discour-
aged from. going from. physician to physician in
the hopes offinding.a 'cure'.
S Atr Med J 1993; 83: 730-733.
Asyndrome characterised by burning vulvar dis-comfon and introital dyspareunia but associatedwith essentially nonnal physical findings was first
described in 1889. ' At that time it was referred to as
hyperaesthesia of the vulva. Inexplicably this problem
virroally disappeared after the turn of the century, and it
was not until the mid-1970s that a concened effon was
made to elucidate its causes. At the 1975 meeting of the
International Society for the Study of Vulvar Diseases
(ISSVD), Weisfogel coined the tenn 'burning vulva'.
The word vulvodynia (based on the Greek odynia
(pain» was suggested for this condition by Tovell and
Young2 in 1978. In 1983, the ISSVD fonned a task
force under the direction of McKay to study this entity
and definitive terminology was published in 1984.'
Vulvodynia is defmed as chronic vulvar discomfort,
especially that characterised by the patient's complaint
of burning and sometimes stinging, irritation or rawness.
Burning vulva syndrome refers to vulvodynia for which
no physical cause can be found or that persists despite
appropriate treatment for associated physical findings.'
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The cause of the syndrome remains contentious.
In 1983 both Woodruff and Parmley' and Friedrich'
reponed pathological findings of infection of the minor
vestibular glands. Subsequently Friedrich6 described a
triad of presenting features which he named the vulvar
vestibulitis syndrome (VVS). These were: (i). severe
pain on vestibular touch or attempted vaginal entry;
(ii) tenderness to pressure localised within the vulvar
vestibule; and (iii) physical findings confined to vestibu-
lar erythema of variable degree. Pyka et at. 7 detailed the
histopathological characteristics of vulvar vestibulitis.
onspecific chronic inflammation in the stroma sur-
rounding the region of the minor vestibular glands was
.present in all patients, but the glandular epithelium and
lumina were not involved. Minor vestibular glands were
noted in 66%. In these cases there was squamous meta-
plasia of the acini and ducts with development of so-
called 'vestibular clefts'. Koilocytosis was present in
27%.
There has been much speculation as to the cause of
vulvar vestibulitis, ranging from various infective agents
to sexual activity. Hypersensitivity to Candida or to
several treatment vehicles was also postulated, but this
was disproved by Marinoff and Turner.' Many physi-
cians have attributed the symptoms solely to psycho-
genic factors.' Recently histopathological studies and
viral DNA detection have shown that in a subset of
patients with vestibulitis the aetiological agent is human
papillomavitus (HPV).9,IO
Apan from the categories of vulvar vestibulitis and
HPV infection (papillomatosis) there are other causes of
vulvodynia or burning vulva syndrome, which can be
classified as follows:" (I) vulvar dennatoses; (ii) essential
or dysaesthetic vulvodynia; (iii) cyclic vulvitis; and (iv)
diverse entities such as neuroma, 12 which we suggest are
included in a miscellaneous category. Benrubi" has
shown that patients may have concurrent or overlapping
causes for their vulvodynia.
Unrealistic expectations and unrewarding medical
experiences contribute to the resentment, frustration
and anger so often expressed by these patients."
The present study of women referred to the senior
author because of his interest in vulvodynia and burning
vulva syndrome delineates the causes of the condition
and evaluates treatment methods.
Subjects and methods
During the past 8 years, 26 white patients between the
ages of 12 and 75 years were referred by gynaecologists
because of recalcitrant symptoms of vulvar burning and
pain. Women with a history of vulvar wartS or previous
treatment for condyloma acuminata were excluded. All
had experienced vulvodynia for at least 6 months, rang-
ing from 6 to 120 months (mean 33, median 24). In
those with consorts, the most prominent symptom was
unbearable vulvar pain at the time of penile penetration.
All patients underwent detailed vulvovaginal assess-
ment. Routine saline wet mount cytological examination
was perfonned and microbiological samples were taken
for culture. A Cytological smear was taken from the cer-
vix, or the vagina in hysterectomised women. Evidence
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FIG. 1.
Histological section of vulval biopsy specimen showing
basal cell hyperplasia, koilocytotic atypia and para-
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Patien ~;th fearures cons' tem with vuh'ar dysa -
thesia and a ociated HPV were included a a ub et
within the category of entia! r d~ a thetic \'Ulvo-
dynia. They received treatment fi r the HP and a com-
binati n of everal modaliti for th dysa th ia. A Ul-
cyclic antidepr ant amioipryline r c10mipramme at
ad e of 10 - 75 mg at night was prescribed. The anti-
convul ant carbamazepine u ed ucc fully in t-
herpes z ter neuralgia" was prescribed in 2 tan-
ing at a d of 100 mg and inere in by ineremen of
100 m every 2 da until a daily d of 60 m was
reached. ppropriate rthopaedic urgery wa per-
f rmed where indicated. ne patient al 0 received
inten ive p ch therapy and flupenthixol I mg dally
wa add d by the p ycbiatri t t the carbamazepme,
cl rnipramine and h'dr xyzine.
• 73 _
FIG. 2.
Histopathological features of HPV infection associated
with a florid chronic inflammatory cell infiltrate in the
underlying stroma with exocytosis into the overlying
epithelium (H and E x 600).
The 5 patients with dysaesthetic vulvodynia were all
postmenopausal, depressed and complained of diffuse
unremitting genital burning exacerbated by coitus.
Their ages ranged from 49 years ro 75 years (mean 61
years). Introital tenderness extended laterally around the
labia majora and sensory testing revealed abnormal
responses. One patient described radiation of discomfon
ro the thighs and 1 re the groin; because this suggested
pudendal neuralgia, the pudendal nerves were infiltrated
by local anaesthetic without anticipated temporary
relief. Although McKayll reponed that rricyclic antide-
pressant therapy was often successful, it proved ineffec-
tual in our patients. CO2 laser vaporisation for associat-
ed HPV lesions in 3 patients was unhelpful. Two in the
larrer subset also had lumbar abnormalities for which
orthopaedic treatment was unsuccessful. Systemic
acyclovir in 1 patient who had high antibody otres for
herpes simplex was unsuccessful. Only I of 5 patients
(20%) has improved partially.
One patient had a mature traumatic neuroma which
was successfully treated by partial vulvecremy.'2 The
patient with lichen planus improved only partially
despite oral methylprednisolone, dapsone, azathioprine,
isotretinoin and topical application of cyclosporin A
solution. The woman with lichen sclerosus experienced
symprematic relief after regular twice-weekly application
of clobetasol proprionate 0,05% cream, a parent ropical
steroid, for 3 months. Although Candida strains were
cultured in 7 patients (27%) and treated appropriately,
only in the youngest patient in the series, aged 12 years,
was Candida considered re have caused the patient's
symptom complex. Her problem of cyclic vulvitis




Histopathological findings in a patient with VVS. Note
the periglandular chronic inflammatory cell infiltrate
with sparing of the minor vestibular gland (arrows) (H
and Ex 250).
TABLE!.





Flat acetowhite with associated VIN III


























This study shows that vulvodynia has many causes bur
three main categories: subclinical HPV, VVS, and
dysaesthesia. Consistent with Benrubi's13 findings, some
patients had concurrent and overlapping causes. All the
patients in our series were white. Furlonge et al. 17 noted
a similar absence of black patients in the UK, as did
Reid et al. 18 in the USA. Both these groups reponed that
92% of their patients were white. It is not yet known
whether white women have a genetic predisposition to
vulvodynia or this finding is explained by a marked
sociocultural difference in response to disease manifesta-
tions. There were two demographic subsets in our
series. Patients with vulvodynia caused by HPV had a
median age of 30 years, whereas the median age of those
with dysaesthesia was 58 years. In the larrer, tricydic
antidepressants and appropriate orthopaedic treatment
failed, raising the possibility of an inflammatory neuritis
which causes decreased A-fibre activity leading to
impairment of rouch and proprioception. 13
Colposcopically directed biopsies are mandatory in
order re obtain appropriate specimens for histopatho-
logical studies, which form the basis for therapeutic
decisions. Acetowhite reactions often affect not only the
vestibular mucosa bur also the adjacent vulvar skin. The
presence of vulvar intra-epithelial neoplasia grade III
against a background of subclinical HPV in I of our
patients is consistent with the recognition that genital
neoplasia may begin with HPV infection. IO The fact th~t
77% of the patients in our series had histopathological
evidence of HPV parallels the alarming increase in the
number of cases seen in the USA. 10,10
The subepithelial chronic inflammatory infiltrate
seen in most patients with HPV may not only be asso-
ciated with an immune response to the virus but causal-
ly related re the tenderness experienced by the patient.
_------------------....J.. ,~
TABLE 11.
Results of treatment for vulvar HPV
Result
CR PR NR
Treatment No. No. % No. % No. %
Conservative 4 2 50 1 25 25
5-fluoro-uracil cream 2 1 50 1 50
CO2 laser vaporisation 7 2 29 2 28 3 43
Intralesional interferon-a: 7 4 58 3 42-
Total 20
CA = complete response; PR = partial response; NR = no response.
Published methods of HPV treatment were utilised.
The small numbers in each therapeutic group (Table IT)
and absence of uniform protocols, placebo controls and
non-blind evaluation render valid conclusions impossi-
ble. However, our results and experience reported by
others permit guidelines. As 2 of 4 cases resolved with
further observation and application of steroid creams, an
initial period of conservative management is indicated.
In 1987 Campion20 concluded that a period of observa-
tion was justified, and in 1992 Coppleson and PixleyZl
concurred with the opinion that a conservative approach
is recommended where possible. Although topical appli-
cation of 5% 5-fluoro-uracil cream as advocated by Reid
et al. 18 proved helpful in 2 patients, this treatment was
abandoned because of accompanying incapacitating
pain during desquamation. Ablation of the affected
epithelium to the first surgical plane using a partially
defocused beam from a CO2 laser, the method of treat-
ment preferred by Reid/2 yielded poor results, consis-
tent with the experience of others. 23
In an effort to find a less invasive form of therapy,
intralesional injection of i.l"lterferon-a-2b was utilised in
7 patients, with complete response in 58%, compared
with 88% reported by Horowitz. 14 Enthusiasm should
be guarded, since Kent and Wisniewski24 reported a
63% complete response rate and Marinoff and Turner"
only 45%. Patients who do not respond can undergo
surgical or laser ablation. The mechanism of the effect
of interferon is still unclear. It appears to stimulate natu-
ral killer cells, which destroy infected cells,14 and binds
to cell surface membrane receptors where it induces
enzymes which prevent viral replication in virus-infected
cells. 24 In addition, it enhances phagocytic activity of
macrophages and augments cytotoxicity of Iympho-
cyres. 24
It is currently accepted that HPV is one of the causes
of the VVS.',I0,2I,25,26 Accordingly, it is not surprising that
in our series 2 of the patients with VVS had HPV and 1
patient with dysaesthetic vulvodynia had HPV and VVS.
Only 1 patient had the histopathological criteria for VVS
described by Pyka et al. 1 The patient with so-called
cyclic vulvitisll caused by chronic candidiasis had clini-
cal features of VVS. Our histopathological findings are
in keeping with those of Furlonge et al. I ' who reported
nonspecific chronic inflammation in 46% and HPV in
38% of patients with VVS. Peckham et al. 27 reported
that histopathological study in their patients with VVS
failed to show a characteristic panern of inflan"lffiation
or an association with the minor vestibular glands. They
cautioned that the operation of vestibulectomy and vagi-
nal advancement, while promising, should only be per-
formed in recalcitrant cases. Reid et al. 18 reported that
their experience with vestibulectomy was unsatisfactory.
Reports of success with the CO2laser are also variable."
The exact causes and preferred treatment of VVS
remain unresolved.
Despite intensive therapy, at the time of last contact
10 of the 26 patients (38%) still had troublesome vulvo-
dynia, indicating that it remains a potentially insoluble
problem and that neither the patient nor the physician
should expect its rapid resolution.
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